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Phaeochromocytoma in children
Phaeochromocytoma is a rare disease in childhood with a subtle and wide
range of clinical presentations. We report two confirmed cases and one po-
tential case of phaeochromocytoma, each belonging to a different disease
spectrum or syndromal disorder, namely sporadic phaeochromocytoma, von
Hippel-Lindau disease, and multiple endocrine neoplasia type 2a. Know-
ledge of the molecular basis of the condition helps to make the diagnosis.
Affected individuals and their family members should be screened for any
associated syndromal disorders that can carry a substantial degree of mor-
bidity and mortality.
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Introduction
Phaeochromocytoma is a rare tumour among children and adolescents. It is
an adrenomedullary catecholamine-secreting tumour that can occur at any age.
Approximately 10% of patients with phaeochromocytoma are children1,2
and, for children with this disease, the incidence peak occurs at the age of 9 to 12
years. Boys are affected more often than girls, with a ratio of 2:1.
The frequency of multiple, bilateral, and extra-adrenal tumours is greater
among children than adults, with the most common site of extra-adrenal involve-
ment being the superior para-aortic region.1
Between January 1986 and June 2001, there were two confirmed and one
potential cases of phaeochromocytoma at the Department of Paediatrics,
Queen Mary Hospital. Each patient had a different clinical syndromal disorder
associated with phaeochromocytoma.
Case reports
Case 1
A 6-year-old boy presented with a history of sweatiness, weight loss, and lethargy.
He was admitted to a hospital in Shanghai due to loss of consciousness 1 year
after the initial presentation. He had a high blood pressure of 200/170 mm Hg.
Abdominal ultrasonography revealed bilateral adrenal masses that were
surgically removed. A small amount of adrenal tissue remained. The pathology
of the resected mass was confirmed to be phaeochromocytoma. Postoperatively,
his blood pressure level remained elevated at 140/100 mm Hg.
At the age of 11 years, he immigrated to Hong Kong and was admitted to
hospital because of persistent sweating and weight loss. His blood pressure was
elevated at 230/110 mm Hg. He was also found to have bilateral ptosis and a
divergent squint. The visual acuity of his left eye was poor. Fundoscopic exami-
nation showed pigmentary change with capillary angioma of the retina invading
the left optic disc. His right eye also had choroidoretinitis. Investigation showed
an elevated 24-hour urine vanillylmandelic acid (VMA) level of 106 µmol/day
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(normal range, 11-38 µmol/day). Ultrasonography of
the abdomen and intravenous urogram were normal.
131I-metaiodobenzylguanidine (131I-MIBG) scan showed
increased uptake in the left submandibular region, right
adrenal bed, and bilateral lower pole of the kidneys. Aorto-
gram showed vascular staining compatible with phaeo-
chromocytoma in the liver, and the right adrenal and lower
left para-aortic regions. Retinal angiogram confirmed
bilateral optic disc angioma (Fig 1). Based on these features,
the patient was diagnosed with von Hippel-Lindau (VHL)
disease. Computed tomography (CT) scanning of the brain
did not show any haemangioblastoma. Family screening of
urine catecholamines, VMA, and homovanillic acid were
normal. The patient was given phenoxybenzamine and pro-
pranolol for blood pressure control.
Surgical resection of the right adrenal tissues with lymph
nodes in the lower left para-aortic region was performed.
Histology confirmed phaeochromocytoma. The patient
required postoperative maintenance antihypertensive
therapy. Follow-up 131I-MIBG scan the next year revealed
an increased uptake over the submandibular region and
right medial thorax at the level of T4. Subsequent imaging,
including CT, 131I-MIBG, and angiogram, showed persist-
ent tumour in the neck region. Surgical resection was
again performed with histology confirming metastatic
phaeochromocytoma. His postoperative blood pressure was
normal, although urine norepinephrine and normetanephrine
levels remained elevated. This patient defaulted follow-up
the year after the first dose of therapeutic 131I-MIBG
treatment.
Case 2
A 10-year-old boy presented to the emergency department
with a 1-day history of diarrhoea. He was incidentally found
to be hypertensive (blood pressure, 200/140 mm Hg). He
also had a history of recurrent central abdominal pain and
headache for 1 year with no sweating, tremor, palpitation,
or chest discomfort. Physical examination was entirely
normal except for the hypertension.
Investigations showed normal thyroid, liver, and
renal functions. Serum aldosterone and cortisol levels were
normal, excluding Conn’s syndrome and Cushing’s
syndrome, respectively. Urine catecholamines and VMA
levels were elevated (norepinephrine, 910 nmol/mmol
creatinine [normal range, 0-60 nmol/mmol creatinine];
normetanephrine, 540 nmol/mmol creatinine [normal range,
0-40 nmol/mmol creatinine]; VMA, 12 µmol/mmol creat-
inine [normal range, 0-5.4 µmol/mmol creatinine]).
Echocardiogram and ultrasonography of the abdomen
were unremarkable although CT scanning of the thorax
and abdomen showed a right thoracic paravertebral mass.
Magnetic resonance imaging (MRI) showed a hyper-
intense T2-weighted lesion measuring 4.6 x 2.5 x 4.3 cm
at the right paraspinal region at level T8 to T11 (Fig 2).
131I-metaiodobenzylguanidine scan confirmed an avid lesion
in the right lower thorax. Immunohistochemical studies
of the resected tumour confirmed phaeochromocytoma.
Family screening did not show the presence of hypertension.
Case 3
An asymptomatic 15-year-old boy was referred because of
a family history of phaeochromocytoma. His father died at
the age of 36 years because of medullary carcinoma of the
thyroid. His 42-year-old paternal aunt had a 4-year history
of hypertension and was subsequently diagnosed to have
phaeochromocytoma.
Physical examination of the patient was unremarkable.
Investigations, including urine catecholamines and VMA,
serum liver and renal function tests, and biochemistry, were
all within the normal ranges. Serum calcitonin was normal
at 4.3 pmol/L. DNA analysis of the patient, his father, and
his paternal aunt all showed germline mutations in codon
634 of exon 11 of the RET proto-oncogene, which was
consistent with that of multiple endocrine neoplasia (MEN)
Fig 2. Magnetic resonance imaging of the thorax showed a
hyperintense T2-weighted phaeochromocytoma measuring
4.6 x 2.5 x 4.3 cm at the right paraspinal region at level T8 to T11
Fig 1. A retinal angiogram of patient 1 with von Hippel-Lindau
disease showed the presence of an optic disc angioma
454      Hong Kong Med J Vol 8 No 6 December 2002
Yeung et al
type 2a and was highly predictive of the development of
phaeochromocytoma. The patient was referred for prophy-
lactic removal of the thyroid gland. Total thyroidectomy
was performed and histology confirmed medullary carcin-
oma of both lobes of the thyroid. Regional lymph node
examination did not show metastasis. Biopsy of the para-
thyroid gland was taken with unremarkable findings. His
adrenal condition has been closely monitored through regular
measurement of urine catecholamines level. There is no
evidence of a tumour evolving so far.
Discussion
The three patients reported here had different clinical
syndromes associated with phaeochromocytoma. Case 1 had
VHL disease, case 2 had isolated sporadic phaeochro-
mocytoma, and case 3 had MEN type 2a with a high possi-
bility of developing phaeochromocytoma later in life.
Syndromes known to be associated with phaeochro-
mocytoma in children include MEN type 2a, 2b (accounting
for 50% of cases), VHL disease (15%), neurofibromatosis
(1%), and tuberous sclerosis.1,2
Unlike in adults, phaeochromocytoma can sometimes
have a vague and non-specific presentation in children.
Hypertension is usually sustained rather than paroxysmal.
Known symptoms such as headache, sweating, nausea,
vomiting, weight loss, fatigue, abdominal pain, emotional
lability, polyuria, polydipsia, constipation, visual disturb-
ance, and cold extremities may or may not be present.
 Patients with MEN type 2a are at risk of developing
medullary carcinoma of the thyroid, phaeochromocytoma,
and parathyroid hyperplasia or tumour. Phaeochromocytoma
is usually bilateral or multifocal within the adrenal glands,
and develops gradually in more than 50% of patients.
The gene for MEN type 2 is mapped to chromosome
10 cen-10q11.2. It is a region containing c-RET-proto-
oncogene, which encodes the tyrosine kinase receptor with
cadherin-like and cysteine-rich extracellular domains, and
tyrosine kinase intracellular domain.3 Ninety-five percent
of cases of MEN type 2a are associated with mutation of
cysteine-rich extracellular domain. Mutations in codon
634 account for 85% of MEN type 2a mutations whereas
mutations in codon 918 account for 95% of MEN type 2b.
von Hippel-Lindau disease is an autosomal dominant
inherited familial cancer syndrome predisposing to retinal
and central nervous system haemangioblastoma, renal cell
carcinoma, renal cysts, phaeochromocytoma, pancreatic
cysts, and tumours. The VHL gene, which functions as
a tumour suppressor gene, is located at chromosome
3p25-26.4
Neurofibromatosis is an autosomal dominant condition
predisposing to the development of tumour in central and
peripheral nervous systems. One percent of patients with
neurofibromatosis have phaeochromocytoma. Gene loci
of neurofibromatosis type 1 and 2 are on chromosomes
17q11.2 and 22q12, respectively.
The genetic basis of familial phaeochromocytoma is not
yet well defined for many families. Recently, Astuti et al5
studied four members of the same family with familial
phaeochromocytoma, and found a frameshift mutation in
the gene encoding succinate dehydrogenase complex sub-
unit D (SDHD) in two generations of a family with four
children with phaeochromocytoma. The SDHD mutation
is rarely found in sporadic phaeochromocytoma. Neither
the germline mutations in the VHL gene nor the c-RET
proto-oncogene is commonly found in sporadic phaeo-
chromocytoma.6
For investigation of phaeochromocytoma, urinary
examination of catecholamines and metabolites is the first
choice for screening as the test is non-invasive and has a
high sensitivity of 100% and specificity of 98%.7,8
Imaging techniques including 131I-MIBG scan, CT,
and MRI are helpful for locating the tumour. Magnetic
resonance imaging has the highest sensitivity (100%), fol-
lowed by CT (98%) and 131I-MIBG (78%). Specificity is
the highest in 131I-MIBG (100%), followed by CT (70%)
and MRI (67%).9 A whole body evaluation by CT/MRI is
suggested for localisation of the tumour if the adrenal glands
are normal because of the high chance of extra-adrenal
involvement. Positive findings should be followed by 131I-
MIBG scan for confirmation because of its high specificity.
Newer imaging techniques such as positron emission tomog-
raphy have been used for locating phaeochromocytoma
with satisfactory results.10 Positron emission tomography is
recommended for patients with suspected phaeochromo-
cytoma and positive biochemical tests but negative results
with conventional imaging studies.
Case 3 has confirmed genetic MEN type 2a and close
monitoring of the evolving phaeochromocytoma is needed.
Since almost all patients with MEN type 2a develop
medullary carcinoma early in their lives, prophylactic
excision of the thyroid gland is mandatory. In fact, the
excised thyroid tissue of case 3 had already shown the
presence of medullary carcinoma. Regular checking of
serum calcium, calcitonin, and parathyroid hormone is
needed because parathyroid hyperplasia is also a known
association of the condition.
Surgery is still the mainstay of treatment for phaeo-
chromocytoma. Before undergoing an operation, however,
the blood pressure must be pharmacologically normalised
to avoid hypertensive crisis during surgery.11,12
In most incidences, phaeochromocytoma may be the
only presenting problem for patients with MEN type 2a
or VHL disease. Universal screening of patients with
phaeochromocytoma to exclude a familial or clinical
syndrome is recommended, especially for young patients
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who have positive family histories or multiple tumours.
The investigations should aim at making the diagnosis and
looking for complications of the syndromal disorder. Apart
from performing the usual investigations, measurements
of serum parathyroid hormone, serum calcium, calcitonin
level, ophthalmoscopy, MRI of the brain, spine, and
abdomen, and even genetic testing of VHL and c-RET genes
are useful screening tests. In view of the high morbidity
associated with the clinical syndromes, early detection of
any associated problems can decrease the complications of
this disease.
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